SCHEMBL7793458

SCHEMBL7793458

CCS(NC(=O)C=Cc1ccccc1)(SCC(NC(=O)C=Cc1ccccc1)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.49
MMP2 P08253 3/20 0.49
MMP9 P14780 3/20 0.49
POLB P06746 1/20 0.49
RECQL P46063 1/20 0.49
ALDH1A1 P00352 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
MAPK1 P28482 1/20 0.45
CYP2C19 P33261 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7793398 0.82 L3MBTL1 (0.46) POLBALDH1A1HDAC3HDAC4HDAC1
SCHEMBL7793442 0.82 POLB (0.43) POLBALDH1A1HDAC1HPGDMEN1
SCHEMBL7799269 0.82 MTNR1A (0.45) POLBLMNA
SCHEMBL7793447 0.81 MMP1 (0.64) MMP1MMP2MMP9POLBRECQL
SCHEMBL7793454 0.81 MMP1 (0.64) MMP1MMP2MMP9POLBRECQL
SCHEMBL7798895 0.79 NPC1 (0.50) HDAC2HDAC8HDAC6MAPTKMT2A
SCHEMBL7802324 0.77 ITGB3 (0.48) MMP9HPGD
SCHEMBL7798890 0.77 NPC1 (0.48) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7798918 0.75 POLB (0.42) MMP9POLBALDH1A1CYP2C9CYP2C19
SCHEMBL7803207 0.74 POLB (0.43) POLBCYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed